drugset / Trial / NCT00425178
FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers
Non-randomizedSingle-groupOpen-labelTreatment
Summary
FGF-1 is being used for the treatment of patients with diabetic or venous stasis ulcers. Procedure includes topical administration of FGF-1 or placebo and evaluation of safety, pharmacokinetics, and wound improvement.
Timeline
- Start
- 2005-09-02
- Primary completion
- 2006-09-02
- Completion
- 2006-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FGF-1 | Protein / enzyme biologic | — | Topical |